Twist Bioscience Return On Equity vs. Cash And Equivalents

TWST Stock  USD 48.12  0.18  0.38%   
Based on the measurements of profitability obtained from Twist Bioscience's financial statements, Twist Bioscience Corp may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Twist Bioscience's ability to earn profits and add value for shareholders.
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
(0.44)
Current Value
(0.42)
Quarterly Volatility
0.49839677
 
Credit Downgrade
 
Yuan Drop
 
Covid
Price To Sales Ratio is likely to drop to 7.96 in 2024. Days Sales Outstanding is likely to drop to 38.67 in 2024. At this time, Twist Bioscience's Net Interest Income is comparatively stable compared to the past year. Interest Income is likely to gain to about 16.1 M in 2024, whereas Net Loss is likely to drop (219.2 M) in 2024.
For Twist Bioscience profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Twist Bioscience to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Twist Bioscience Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Twist Bioscience's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Twist Bioscience Corp over time as well as its relative position and ranking within its peers.
  

Twist Bioscience's Revenue Breakdown by Earning Segment

Check out World Market Map.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.60)
Revenue Per Share
5.119
Quarterly Revenue Growth
0.278
Return On Assets
(0.16)
Return On Equity
(0.38)
The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Twist Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Twist Bioscience Corp Cash And Equivalents vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Twist Bioscience's current stock value. Our valuation model uses many indicators to compare Twist Bioscience value to that of its competitors to determine the firm's financial worth.
Twist Bioscience Corp is rated below average in return on equity category among its peers. It is rated below average in cash and equivalents category among its peers . At this time, Twist Bioscience's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Twist Bioscience by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Twist Cash And Equivalents vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Twist Bioscience

Return On Equity

 = 

Net Income

Total Equity

 = 
-0.38
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Twist Bioscience

Cash

 = 

Bank Deposits

+

Liquidities

 = 
504.97 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Twist Cash And Equivalents Comparison

Twist Bioscience is currently under evaluation in cash and equivalents category among its peers.

Twist Bioscience Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Twist Bioscience, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Twist Bioscience will eventually generate negative long term returns. The profitability progress is the general direction of Twist Bioscience's change in net profit over the period of time. It can combine multiple indicators of Twist Bioscience, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-522 K-495.9 K
Net Interest Income15.3 M16.1 M
Interest Income15.3 M16.1 M
Operating Income-220.8 M-209.8 M
Net Loss-208.7 M-219.2 M
Income Before Tax-208.2 M-218.6 M
Total Other Income Expense Net12.7 M13.3 M
Net Loss-196.1 M-186.3 M
Net Loss-208.7 M-219.2 M
Income Tax Expense560 K588 K
Non Operating Income Net Other7.6 M7.9 M
Change To Netincome94.7 M99.4 M
Net Loss(3.60)(3.78)
Income Quality 0.31  0.29 
Net Income Per E B T 1.00  1.10 

Twist Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Twist Bioscience. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Twist Bioscience position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Twist Bioscience's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Twist Bioscience without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Risk-Return Analysis Now

   

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
All  Next Launch Module

Use Investing Themes to Complement your Twist Bioscience position

In addition to having Twist Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Printing and Publishing Thematic Idea Now

Printing and Publishing
Printing and Publishing Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Printing and Publishing theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Printing and Publishing Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Twist Stock Analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.